Powerful Medical Receives €40 Million IPCEI Grant — read the full story

PM Magazine

Powerful Medical team receiving the MedTech Innovator 2025 Mid-Stage Grand Prize award on stage, holding a large winner’s check.

Powerful Medical Wins MedTech Innovator 2025

Powerful Medical has been named MedTech Innovator 2025, winning MTI’s Mid-Stage Grand Finals—top honor from the world’s largest medtech accelerator. The award recognizes PMcardio and its FDA Breakthrough-designated Queen of Hearts™ AI ECG technology, which doubles sensitivity for detecting severe heart attacks and significantly cuts ECG-to-balloon time in large clinical trials.

Editor's Choice

PMcardio Reports Positive RCT Results and Late-Breaking Clinical Science for STEMI Detection

28. October 2025
Doctor holding Roche cobas® pulse point-of-care device displaying PMcardio AI-powered ECG interpretation for real-time heart attack detection at the patient bedside.

PMcardio Expands Heart Attack Detection to Patient Bedside through Roche cobas® pulse Point of Care Platform

21. August 2025
Powerful Medical awarded €40M IPCEI grant to expand AI diagnostics for heart attacks, heart failure, and arrhythmias

Powerful Medical Receives €40 Million Non-Dilutive Grant to Accelerate Early Diagnosis of Cardiovascular Diseases with AI

28. July 2025
Dr. Joseph Banno

Dr. Banno Pins Down Subtle STEMI Case Using PMcardio’s OMI AI Model

This case highlighted the limitations of traditional diagnostic methods and led Dr. Banno to explore innovative solutions for cardiac care. This exploration introduced him to the PMcardio tool, an AI-powered clinical decision support system for ECG interpretation
Dr. Christopher R. Schmelzer, MD

Dr. Schmelzer’s Turning Point: How a Severe Chest Pain Case Inspired PMcardio Adoption

The case of a 76-year-old patient with severe chest pain prompted Dr. Schmelzer to delve into the nuances of Occlusive Myocardial Infarction (OMI) versus the conventional STEMI/NSTEMI classification. His research led him to discover the PMcardio OMI AI model.

Stay on the pulse with our newsletter

Your submission was successful